Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Ep6.5
Epicatechin – Forschung
Hilft vermutlich
44 begutachtete Studien
Was die Evidenz sagt
Hilft vermutlich
Epicatechin half in etwa der Hälfte (10/17) der Studien, die einen Effekt gemessen haben — vielversprechend, aber nicht einhellig.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 2005–2026 mit einer typischen Studiengröße von 219 Teilnehmenden.
Basierend auf 44 Studien · 7 Meta-Analysen · 20 RCTs · 1,102,760 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
10geholfen7unklar· 27 weitere ohne bewertete Effektdaten
Nach Outcome
Cardiovascular & endothelialVerbessert die Endothelfunktion und die Stickstoffmonoxid-Produktion · 4-8 weeks
Hilft vermutlich37 Studien
Glucose & metabolic
Gemischte Evidenz12 Studien
Bioavailability & pharmacokinetics
Überwiegend Mechanismus / Beobachtung8 Studien
Skeletal muscle & sarcopeniaKein nachgewiesener Effekt auf Muskulatur oder Myostatin beim Menschen; Nutzen nicht belegt · 4-8 weeks
Überwiegend Mechanismus / Beobachtung5 Studien
InflammationVerbesserte Endothelfunktion und Durchblutung · 2-4 weeks
Überwiegend Mechanismus / Beobachtung5 Studien
Therapeutic & clinical
Überwiegend Mechanismus / Beobachtung5 Studien
Cognitive function
Überwiegend Mechanismus / Beobachtung4 Studien
Bone health
Überwiegend Mechanismus / Beobachtung3 Studien
Endurance & exercise performanceKein Nutzen; eine kontrollierte Studie ergab, dass Epicatechin die aeroben und mitochondrialen Trainingsanpassungen abschwächte · 4-8 weeks · Keine Belege für einen Leistungsnutzen beim Menschen; kann die Anpassung an Ausdauertraining beeinträchtigen · 4-8 weeks
Zu wenige bewertete Studien2 Studien
Vision & eye health
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 37 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
50%
über Studien hinweg
Untersuchte Personen
1103k
typische Studie: 219 Personen
Stärkste Designs
27
7 gepoolt, 20 randomisiert
Zeigte Nutzen
59%
10/17 Studien
Wie lange Studien liefen
Unter einer Woche
2
3+ Monate
4
Untersuchte Populationen
Healthy adults4
General population3
Older adults2
Diverse populations1
Aktives Forschungsgebiet
29 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
200520152026
1Office systolic blood pressureMeta-AnalyseCited 6×n=5,205 · very large study2025
Flavan-3-ol-rich foods considerably reduce elevated BP and improve endothelial function independent of blood pressure supporting their use for cardiovascular prevention.
Lagou V et al. · European journal of preventive cardiology (2025)
Spürbar Nutzen
← SchlechterKein EffektBesser →
Flavan-3-ol interventions included epicatechin, epigallocatechin-gallate, cocoa products, tea, grape extract, and apples delivering 586 mg (95% CI 510, 662) total flavan-3-ols.
Interventions decreased office (-2.8 [95% CI -3.9, -1.7]/-2.0 [-2.6, -1.3] mmHg) and 24 h-ambulatory BP (-3.7 [-5.8, -1.6]/-2.6 [-4.5, -0.8] mmHg) after chronic repetitive consumption.
Flow-mediated dilation increased after acute (+2.0% [1.6, 2.3]) and repetitive (+1.7% [1.3, 2.2]) consumption independent of BP.
Collectively, the results highlight that epicatechin has the therapeutic potential for preventing or mitigating oxidative stress-related cognitive dysfunction.
Yoon YC et al. · Journal of agricultural and food chemistry (2025)
At the molecular level, epicatechin treatment increased the expression or activity of superoxide dismutase, catalase, and nuclear factor erythroid 2-related factor 2 and reduced the levels of nitric oxide, malondialdehyde, tumor necrosis factor-alpha, and interleukin-1 beta.
These findings support the role of epicatechin in enhancing antioxidant defense and modulating neuroinflammation.
Collectively, the results highlight that epicatechin has the therapeutic potential for preventing or mitigating oxidative stress-related cognitive dysfunction.
5CrossFit performanceSystematische ÜbersichtCited 19×n=219 · medium study2021
These outcomes may have been obtained due to methodological limitations such as small sample size, lack of control over influencing variables, short period of exercise intervention.
Dos Santos Quaresma MVL et al. · Nutrition (Burbank, Los Angeles County, Calif.) (2021)
These outcomes may have been obtained due to methodological limitations such as small sample size, lack of control over influencing variables, short period of exercise intervention.
Despite the popularity and growing evidence about CF, little is known about the relationship between performance-enhancing substances or dietary interventions and CF performance.
Given the lack of scientific evidence, new studies with potential ergogenic supplements, a better methodological model, and practical application are required.
However, there is no protocol standardization or enough clinical evidence to draw more specific conclusions on its therapeutic implementation.
German IJS et al. · Nutrients (2024)
Epicatechin showed positive effects on follistatin and on the stimulation of factors related to the myogenic actions (MyoD, Myf5, and myogenin).
Furthermore, the literature also showed that epicatechin can interfere with mitochondrias' biosynthesis in muscle fibers, stimulation of the signaling pathways of AKT/mTOR protein production, and amelioration of skeletal musculature performance, particularly when combined with physical exercise.
Epicatechin can, for these reasons, exhibit clinical applicability due to the beneficial results under conditions that negatively affect the skeletal musculature.
Flavonoids may have a great potential to treat sarcopenia.
Wu C et al. · Nutrients (2023)
Skeletal muscle mass significantly increased in three studies, muscle strength significantly elevated in two studies, and physical performance significantly improved in two studies.
RCTs evaluated the main outcomes of tea catechins, epicatechin, and isoflavones intervention.
The majority of studies (five in six) found at least one of the main outcomes is elevated by flavonoids intervention.
They contributed to the bioavailability of flavan-3-ols for over 20%.
Di Pede G et al. · Molecular aspects of medicine (2023)
Kein klarer Effekt
← SchlechterKein EffektBesser →
They contributed to the bioavailability of flavan-3-ols for over 20%.
Mean bioavailability for flavan-3-ols was moderate (31 ± 23%, n bioavailability values = 20), and it seems to be scarcely affected by the amount of ingested compounds.
This highlights the need to better clarify the metabolic yield with which monomer flavan-3-ols and proanthocyanidins are metabolized in humans.
9Kidney stone prevention and managementMeta-AnalyseCited 108×2018
Further investigations are required to confirm the safety and efficacy of these compounds.
Nirumand MC et al. · International journal of molecular sciences (2018)
The main underlying mechanisms of these dietary plants and their isolated phytonutrients in the management of urolithiasis include diuretic, antispasmodic, and antioxidant activity, as well as an inhibitory effect on crystallization, nucleation, and aggregation of crystals.
The results as presented in this review demonstrate the promising role of dietary plants and phytophenols in the prevention and management of kidney stones.
Further investigations are required to confirm the safety and efficacy of these compounds.
10Cardiometabolic parametersSystematische ÜbersichtCited 9×n=11 · very small study2022
Unbiased RCTs on the impact of an EC intake are needed, which should also investigate the additive or synergistic effects of EC with other cocoa ingredients.
Dicks L et al. · Nutrients (2022)
For most trials, some concerns exist for overall RoB.
Thus, EC intake may improve endothelial function in healthy young adults.
For further parameters (mostly secondary outcomes), it remains unclear if EC has no effect or if this was not detectable.
However, the available evidence is very diverse and future studies may address the identified sources of variation to strengthen current evidence on this promising field.
Barrera-Reyes PK et al. · Plant foods for human nutrition (Dordrecht, Netherlands) (2020)
Memory (n = 5) and executive function (n = 4) showed the most significant effects with medium and large effect sizes after intake of intermediate doses of cocoa flavanols (500-750 mg/day).
Effects on cognitive function were observed after consumption of 50 mg/day of (-)-epicatechin and in studies using a component-matched placebo and cocoa as the polyphenol vehicle given to healthy adults (18-50 years).
Overall, this set of studies suggest a positive effect of cocoa polyphenols on memory and executive function.
This meta-analysis provides evidence that cocoa flavanols could significantly improve endothelial function, with an optimal effect observed with 710 mg total flavanols, 95 mg (-)-epicatechin or 25 mg (+)-catechin.
Sun Y et al. · Food & function (2019)
Kaum spürbar Nutzen
← SchlechterKein EffektBesser →
A significant improvement of FMD by 1.17% (95% CI: 0.76% to 1.57%) was calculated, with strong evidence of a non-linear association (inverted U-shape) between cocoa flavanols and FMD.
This meta-analysis provides evidence that cocoa flavanols could significantly improve endothelial function, with an optimal effect observed with 710 mg total flavanols, 95 mg (-)-epicatechin or 25 mg (+)-catechin.
However, there was substantial variation in the results that could not be explained by the characteristics that we explored, and there were significant risk-of-bias concerns with a large majority of the studies.
The present analysis suggests that flavonoid bioactivity does not follow a classical linear dose-response association and this may have important biological implications.
Kay CD et al. · Molecular nutrition & food research (2012)
The present analysis suggests that flavonoid bioactivity does not follow a classical linear dose-response association and this may have important biological implications.
Pathak G et al. · Phytotherapy research : PTR (2026)
Compounds such as quercetin, catechin, naringenin, and epicatechin have shown significant improvements in glycemic parameters and antioxidant enzymes in both preclinical and clinical studies.
However, challenges remain regarding bioavailability, optimal dosing, and safety profiles, particularly in vulnerable populations, including pregnant women.
Future directions should prioritize nano-formulations to improve pharmacokinetics.
15Epigenetic aging clocks (PCGrimAge)RCTn=958 · large study2026
Li S et al. · Nature medicine (2026)
Spürbar Nutzen
← SchlechterKein EffektBesser →
MVM had a stronger effect on PCGrimAge among those with accelerated biological aging at baseline (-0.236 [-0.380 to -0.091]) compared with those with normal or decelerated biological aging (-0.013 [-0.130 to 0.104]; P = 0.018 for interaction).
Cocoa extract did not have an effect on the five epigenetic clocks tested.
16Cardiovascular and liver disease risk factorsSystematische Übersicht2026
Further large-scale, long-term trials are needed to confirm these beneficial effects and to standardize the dosage and formulation of cocoa flavanols.
Tomaru JM et al. · Nutrients (2026)
These findings suggest a potential role for cocoa flavanol-rich dark chocolate in cardiometabolic health; however, the evidence remains preliminary and is limited by heterogeneous study designs, small sample sizes, and short intervention durations.
Despite these limitations, current evidence supports the inclusion of moderate dark chocolate consumption as a possible adjunct strategy to mitigate cardiometabolic and hepatic metabolic risks.
Further large-scale, long-term trials are needed to confirm these beneficial effects and to standardize the dosage and formulation of cocoa flavanols.
Based on available information, maximum health benefits may be achieved if mature Sorbus domestica L. fruits are consumed approximately two weeks after harvest or as unripe fruit-based fermented products.
Penzes N et al. · Nutrients (2026)
Despite existing preclinical evidence, there is a significant gap in clinical trials evaluating the direct impact of polyphenols mentioned above on bone health in humans.
Therefore, further research is needed to confirm their effectiveness in clinical settings.
The therapeutic potential of the most common polyphenols from Sorbus domestica L. fruits has been evaluated by available in vitro and in vivo studies, which highlight their promising potential as dietary interventions to prevent bone loss and improve skeletal integrity in metabolic bone diseases.
19Global cognitive functionRCTCited 10×n=573 · large study2024
Among 573 older adults who underwent repeat in-person, detailed neuropsychological assessments over 2 y, daily CE supplementation, compared with placebo, showed no overall benefits for global or domain-specific cognitive function.
Vyas CM et al. · The American journal of clinical nutrition (2024)
Kein klarer Effekt
← SchlechterKein EffektBesser →
Participants' mean age (standard deviation) was 69.6 (5.3); 49.2% were females.
Daily supplementation with CE, compared with placebo, had no significant effect on 2-y change in global cognition {mean difference [95% confidence interval (CI)]: -0.01 (-0.08, 0.05) standard deviation units (SU)}.
CE, compared with placebo, had no significant effects on 2-y change in episodic memory [mean difference (95% CI): -0.01 (-0.13, 0.10) SU] or executive function/attention [mean difference (95% CI): 0.003 (-0.07, 0.08) SU].
20Incident hypertensionRCTCited 2×n=442 · medium study2025
In older adults, long-term cocoa extract supplementation did not reduce the overall risk of self-reported incident hypertension.
Hamaya R et al. · Hypertension (Dallas, Tex. : 1979) (2025)
Kein klarer Effekt
← SchlechterKein EffektBesser →
Mean age at baseline was 71.1 years (SD, 6.2), and 59% were women.
Over a median follow-up of 3.4 years, cocoa extract supplementation had no significant effect on incident hypertension in an intention-to-treat analysis, with incidence rates of 7.1 and 7.4 per 100 person-years in cocoa and placebo groups, respectively (hazard ratio, 0.96 [95% CI, 0.88-1.05]).
In older adults, long-term cocoa extract supplementation did not reduce the overall risk of self-reported incident hypertension.